Associated Papers
Functional characterization of all CDKN2A missense variants and comparison to in silico models of pathogenicity.
Kimura H et al.
Elife, 2025
40238651 (PubMed )
Supplement: elife-95347-fig2-figsupp3-data1.xlsx › Figure_2-figure_supplement_3A
Functional characterization of all CDKN2A missense variants and comparison to in silico models of pathogenicity.
Kimura H et al.
Biorxiv : the Preprint Server for Biology, 2025
38234851 (PubMed )
Supplement: media-2.pdf
Distinct senescence mechanisms restrain progression of dysplastic nevi.
Lorbeer FK et al.
Pnas Nexus, 2024
38371417 (PubMed )
Supplement: pgae041_supplementary_data.zip › PNASNEXUS-PNASNEXUS-2023-00943R-s05.pdf
Distinct senescence mechanisms restrain progression of dysplastic nevi.
Lorbeer FK et al.
Biorxiv : the Preprint Server for Biology, 2023
BRAF(V600E) Kinase Domain Duplication Identified in Therapy-Refractory Melanoma Patient-Derived Xenografts.
Kemper K et al.
Cell Reports, 2016
27320919 (PubMed )
Supplement: mmc2.xlsx › Mutation_matrix
Clinical features predicting identification of CDKN2A mutations in Italian patients with familial cutaneous melanoma.
Pedace L et al.
Cancer Epidemiology, 2011
Select a paper to view details